Jubilant Biosys Announces Major Capacity Expansions For Its Drug Discovery Services
A Bangalore-based Contract Research Organization (CRO), Jubilant Biosys announced the commencement of two expansion projects in Greater Noida and Bengaluru.
- (1888PressRelease) September 15, 2020 - As the demand for its range of functional and integrated drug discovery services surges, Jubilant Biosys started working on brand new and state-of-the-art chemistry services labs at the sites.
The chemistry FTE capacity is likely to be doubled and operations are expected to commence from the second half of 2020. The new site can provide sufficient space for up to 500 Chemistry FTEs. The site will be designed for the highest global compliance standards to deliver superior speed and quality in the drug discovery process.
A completely new drug discovery services site will be constructed for further expansions in Bangalore. In addition, Jubilant Biosys has formed a new digital business unit comprising of Bio-Informatics, Data curation for AI/ML, Trial Stat EDC software as well as discovery focused AI/ML capabilities.
About Jubilant Biosys Limited:
Jubilant Biosys, a subsidiary of Jubilant Life Sciences Limited, is a Contract Research Organization with its R&D centers in India and business offices in Asia and North America. Jubilant Biosys specializes in comprehensive drug discovery services, analytical chemistry services, synthetic chemistry services, and discovery informatics services for the global pharmaceutical industry.
In order to be the preferred collaborator in the drug discovery domain, Jubilant Biosys is committed to comply with and continually improve its quality systems to provide the following services:
Contract Research
Pre-clinical CRO
Drug Discovery
Virtual Screening
Protein Crystallization
Toxicology & In-vitro ADME
Medicinal Chemistry
Synthetic & Developmental Chemistry
Pharmacology
Jubilant Biosys at a Glance:
A boutique CRO with a talented team of 700+ scientists
New and adaptable technologies to accelerate drug discovery and improve decision-making quality
A highly experienced scientific team that has delivered 75+ integrated discovery programs
Continuous investment in the future of drug discovery and development through expansion
Leadership with a global presence in the US, EU, and Japan
With having strong clinical development, Jubilant Biosys has risen as a fully integrated contract research organization in India and headquartered at Bengaluru with end-to-end solutions.
For more info: https://www.jubilantbiosys.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam